Analgesia
Conditions
Brief summary
The superior hypogastric plexus (SHP) is a retroperitoneal structure with a predominance of afferent sympathetic nerve fibers. The perception of central pelvic pain is thought mainly to involve transmission through this plexus. Therefore, blocking or of SHP has been used to treat pelvic pain.
Detailed description
Ultrasound guided superior hypogastric plexus block there is 2 equal groups: Group S (SHPB group 18 patients) ultrasound guided SHPB is done after induction of balanced general anesthesia (fentanyl, propofol and rocuronium) using 20 ml Bupivacaine 0.5% before skin incision, Group C (Control group 18 patients) in which same technique will be done but using normal saline 0.9% instead of bupivacaine. Patients of both groups will receive patient controlled analgesia using morphine with continous background infusion of morphine 1.5 mg/h with adding granisterone 2mg/60 ml and ability to give bolus of 0.5 mg morphine on demand. • Dosing and administration; Group S (SHPB group 18 ultrasound guided SHPB ) using 20 ml Bupivacaine 0.5% before skin incision. Group C (Control group 18 patients) in which same technique will be done but using normal saline 0.9%
Interventions
PROCEDURESuperior Hypogastric Plexus Block
Pre operative ultrasound guided superior hypogastric plexus block in pelvic surgeries using a curvilinear probe below umbalicus with needle in plane technique to reach the plexus in front of L5 vertebra
Sponsors
National Cancer Institute, Egypt
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
Randomization is done using computer generated sequence. Concealment will be achieved by opaque envelope.
Intervention model description
Group S (SHPB group 18 ultrasound guided SHPB ) using 20 ml Bupivacaine 0.5% before skin incision. Group C (Control group 18 patients) in which same technique will be done but using normal saline 0.9%
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* ASA II,III. * Patients undergoing pelvic surgeries.
Exclusion criteria
* Patients refusal, * Coagulopathy, * Infection.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| morphine consumption | baseline till 24 hours postoperative | Total 24 hours morphine consumption in milligrams |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual analogue scale (VAS) | Visual analogue scale (VAS) at baseline till 24 hours postoperative | scale in which 0 is least pain and 10 is sever pain |
Countries
Egypt
Outcome results
None listed